Cytokinetics Inc (CYTK)
Healthcare
Biotechnology
76.50 $
-0.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -145 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -122 | -96 | -74 | -130 | -99 | -102 | -66 | -132 | -128 | -108 | -143 | -145 | -524 | |
| 1.9 | 1.9 | 6.3 | 2.3 | 2.4 | 2.4 | 2.4 | 2.3 | 2.3 | 2.7 | 2.9 | 3.4 | 11 | |
| 19 | 19 | 19 | 22 | 25 | 25 | 26 | 24 | 28 | 31 | 31 | 30 | 119 | |
| 29 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -24 | 1.5 | 45 | -26 | 9.8 | 9.9 | 42 | -5.2 | -51 | 23 | -1.8 | -0.2 | -31 | |
| 0.7 | 0.2 | 0.1 | 1.8 | 1.9 | 2.5 | 1.3 | 5.7 | 4.1 | 9.4 | 5.6 | 5.9 | 25 | |
| 82 | 73 | -81 | 33 | -652 | -45 | 111 | 106 | 53 | -71 | -71 | 145 | 56 | |
| – | – | 15 | 30 | – | 17 | – | – | 14 | 21 | – | 11 | – | |
| -0.2 | – | – | – | – | -2.9 | -2.9 | -2.9 | -2.7 | 324 | -2.7 | -2.7 | 316 | |
| 5.5 | 54 | 169 | 104 | 821 | 3.4 | 2.4 | 4.8 | 79 | 330 | 111 | 7.8 | 527 | |
| -34 | 31 | 13 | 7.0 | 70 | -143 | 48 | -21 | 2.5 | 152 | -103 | 7.3 | 59 | |
| -123 | -96 | -74 | -128 | -101 | -104 | -67 | -137 | -132 | -117 | -148 | -151 | -549 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.